BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36669880)

  • 61. [Susceptibility to 6-mercaptopurine toxicity related with NUDT15 and ABCC4 variants in Japanese childhood acute lymphoblastic leukemia].
    Tanaka Y
    Rinsho Ketsueki; 2017; 58(8):950-956. PubMed ID: 28883280
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.
    Landier W; Hageman L; Chen Y; Kornegay N; Evans WE; Bostrom BC; Casillas J; Dickens DS; Angiolillo AL; Lew G; Maloney KW; Mascarenhas L; Ritchey AK; Termuhlen AM; Carroll WL; Relling MV; Wong FL; Bhatia S
    J Clin Oncol; 2017 May; 35(15):1730-1736. PubMed ID: 28339328
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Impact of
    Ruel NM; Nguyen KH; Kim CS; Andrade LPS; Hammond JR
    J Pharmacol Exp Ther; 2022 Sep; 382(3):335-345. PubMed ID: 35798387
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia.
    Albayrak M; Konyssova U; Kaya Z; Gursel T; Guntekin S; Percin EF; Kocak U
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1155-9. PubMed ID: 21400026
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical Application of Thiopurine Pharmacogenomics in Pediatrics.
    Pavlovic S; Kotur N; Stankovic B; Gasic V; Lucafo M; Decorti G; Zukic B
    Curr Drug Metab; 2020; 21(1):53-62. PubMed ID: 32124692
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Leukemia Relapse-Associated Mutation of NT5C2 Gene is Rare in de Novo Acute Leukemias and Solid Tumors.
    Oh HR; Choi YJ; Yoo NJ; Lee SH
    Pathol Oncol Res; 2016 Jan; 22(1):223-4. PubMed ID: 26259531
    [No Abstract]   [Full Text] [Related]  

  • 67. Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine.
    Dervieux T; Médard Y; Verpillat P; Guigonis V; Duval M; Lescoeur B; Suciu S; Vilmer E; Jacqz-Aigrain E
    Leukemia; 2001 Nov; 15(11):1706-12. PubMed ID: 11681411
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cytosolic 5'-Nucleotidase II Is a Sensor of Energy Charge and Oxidative Stress: A Possible Function as Metabolic Regulator.
    Pesi R; Allegrini S; Balestri F; Garcia-Gil M; Cividini F; Colombaioni L; Jordheim LP; Camici M; Tozzi MG
    Cells; 2021 Jan; 10(1):. PubMed ID: 33477638
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mutations in PRPS1 causing syndromic or nonsyndromic hearing impairment: intrafamilial phenotypic variation complicates genetic counseling.
    Gandía M; Fernández-Toral J; Solanellas J; Domínguez-Ruiz M; Gómez-Rosas E; Del Castillo FJ; Villamar M; Moreno-Pelayo MA; Del Castillo I
    Pediatr Res; 2015 Jul; 78(1):97-102. PubMed ID: 25785835
    [TBL] [Abstract][Full Text] [Related]  

  • 70. S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts.
    Milek M; Karas Kuzelicki N; Smid A; Mlinaric-Rascan I
    Biochem Pharmacol; 2009 Jun; 77(12):1845-53. PubMed ID: 19428339
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Application of genome editing technology for the validation of pharmacogenomics in acute lymphoblastic leukemia].
    Akahane K
    Rinsho Ketsueki; 2022; 63(11):1566-1579. PubMed ID: 36476799
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia.
    Mansur MB; Furness CL; Nakjang S; Enshaei A; Alpar D; Colman SM; Minto L; Irving J; Poole BV; Noronha EP; Savola S; Iqbal S; Gribben J; Pombo-de-Oliveira MS; Ford TM; Greaves MF; van Delft FW
    Cancer Med; 2021 Jul; 10(14):4864-4873. PubMed ID: 34080325
    [TBL] [Abstract][Full Text] [Related]  

  • 73. APEX1 Polymorphism and Mercaptopurine-Related Early Onset Neutropenia in Pediatric Acute Lymphoblastic Leukemia.
    Kim H; Seo H; Park Y; Min BJ; Seo ME; Park KD; Shin HY; Kim JH; Kang HJ
    Cancer Res Treat; 2018 Jul; 50(3):823-834. PubMed ID: 28882023
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia.
    Kawamura M; Kikuchi A; Kobayashi S; Hanada R; Yamamoto K; Horibe K; Shikano T; Ueda K; Hayashi K; Sekiya T
    Blood; 1995 May; 85(9):2546-52. PubMed ID: 7727782
    [TBL] [Abstract][Full Text] [Related]  

  • 75. PRPS1 silencing reverses cisplatin resistance in human breast cancer cells.
    He M; Chao L; You YP
    Biochem Cell Biol; 2017 Jun; 95(3):385-393. PubMed ID: 28177767
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia.
    Adam de Beaumais T; Jacqz-Aigrain E
    Eur J Clin Pharmacol; 2012 Sep; 68(9):1233-42. PubMed ID: 22421815
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study.
    Camitta B; Leventhal B; Lauer S; Shuster JJ; Adair S; Casper J; Civin C; Graham M; Mahoney D; Munoz L
    J Clin Oncol; 1989 Oct; 7(10):1539-44. PubMed ID: 2778483
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia.
    Moriyama T; Nishii R; Lin TN; Kihira K; Toyoda H; Jacob N; Kato M; Koh K; Inaba H; Manabe A; Schmiegelow K; Yang JJ; Hori H
    Pharmacogenet Genomics; 2017 Jun; 27(6):236-239. PubMed ID: 28445187
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Intensive oral methotrexate protects against lymphoid marrow relapse in childhood B-precursor acute lymphoblastic leukemia.
    Winick N; Shuster JJ; Bowman WP; Borowitz M; Farrow A; Jacaruso D; Buchanan GR; Kamen BA
    J Clin Oncol; 1996 Oct; 14(10):2803-11. PubMed ID: 8874342
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dual origin of relapses in retinoic-acid resistant acute promyelocytic leukemia.
    Lehmann-Che J; Bally C; Letouzé E; Berthier C; Yuan H; Jollivet F; Ades L; Cassinat B; Hirsch P; Pigneux A; Mozziconacci MJ; Kogan S; Fenaux P; de Thé H
    Nat Commun; 2018 May; 9(1):2047. PubMed ID: 29795382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.